Skip to main
TEM
TEM logo

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Tempus AI Inc demonstrated significant growth, delivering 72.5k NGS tests in 3Q24, a notable increase from both the previous quarter and the same period last year. Revenue surged by 35.9% year-over-year, mainly propelled by a 30.6% increase in Genomics revenue to $120.4 million, and a robust 44.6% growth in the Data & Other segment to $80.2 million. Furthermore, the company projects core growth of approximately 30%, with the Data business expected to expand even faster, indicating a strong long-term growth trajectory alongside an expected EBITDA burn improvement.

Bears say

The financial outlook for Tempus AI Inc appears negative due to several key factors, including the potential decline in reimbursement rates, which could adversely affect the company's growth rate and ability to monetize its dataset. Furthermore, the competitive landscape in the healthcare and artificial intelligence sectors presents substantial risks, particularly if Tempus were to lose market share in genomic testing or key health system customers. Lastly, despite an EV/revenue multiple of 8.3x projected for FY25, which trades at a discount compared to its peers, the flat year-over-year operating cash flow and high debt levels raise concerns regarding financial stability and operational efficiency.

TEM has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 2 analysts, TEM has a Buy consensus rating as of Aug 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $72.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $72.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.